Ironwood Pharmaceuticals

Ironwood Pharmaceuticals is a Boston-based gastrointestinal (GI) healthcare company focused on drug discovery and development for GI diseases. Its flagship product is LINZESS (linaclotide), a treatment for irritable bowel syndrome with constipation and chronic idiopathic constipation. The company is publicly traded on Nasdaq under the ticker IRWD.